CLOSED
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care. Track Poly Medicure Limited's live NSE:POLYMED share price ₹1,726.90 (+1.46%), market cap ₹₹175B, P/E 54.3. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for POLYMED — real-time NSE India stock intelligence.
Open
₹1,723.50
High
₹1,749.00
Low
₹1,708.90
Prev. Close
₹1,702.00
52W High
₹2,144.90
52W Low
₹1,182.00
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care
Key Takeaway
Poly Medicure Limited is rated none with a P/E of 54.3x — understand the valuation context before sizing a position.
★ Recommended
Ask AI: Is Poly Medicure Limited fairly valued right now?
Because a P/E of 54.3x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting Poly Medicure Limited
Because the investment case must account for macro and company-specific developments — events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Healthcare moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
535 Cr
Revenue
65 Cr
Net Profit
10.8%
ROE
0%
ROCE
31.83
EPS
| ₹ in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 1,109 | 1,366 | 1,670 | 1,875 | 1,876 |
| Net Profit | 179 | 258 | 339 | 331 | 321 |
| ROE (%) | — | — | — | 10.8% | 10.8% |
| EPS (₹) | — | — | — | 31.83 | 31.83 |
| Debt/Equity | — | — | — | 11.2 | 11.2 |